Clinical Trials
3
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction
Recruiting
- Conditions
- Breast ReconstructionBreast Cancer Female
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- DOF Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06555614
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM® Recon) in Breast Reconstruction
Recruiting
- Conditions
- Breast Cancer FemaleBreast Reconstruction
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- DOF Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06555692
- Locations
- 🇰🇷
Soon Chun Hyang University Hospital, Seoul, Korea, Republic of
Evaluation of ADM(SC Derm® Recon) in Breast Reconstruction
Recruiting
- Conditions
- Breast Cancer Female
- First Posted Date
- 2024-08-14
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- DOF Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06553859
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
News
No news found